Previous Close | 176.99 |
Open | 176.86 |
Bid | 176.80 x 1000 |
Ask | 186.69 x 800 |
Day's Range | 175.03 - 178.28 |
52 Week Range | 155.72 - 186.69 |
Volume | |
Avg. Volume | 7,687,608 |
Market Cap | 467.313B |
Beta (5Y Monthly) | 0.72 |
PE Ratio (TTM) | 26.53 |
EPS (TTM) | 6.69 |
Earnings Date | Apr 18, 2022 - Apr 22, 2022 |
Forward Dividend & Yield | 4.52 (2.56%) |
Ex-Dividend Date | May 23, 2022 |
1y Target Est | 191.42 |
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Moody's outlook for pharmaceutical industry as well as reports that Pfizer is looking to provide additional COVID-19 vaccine doses.
People taking a commonly-used drug for inflammatory conditions such as rheumatoid arthritis or psoriasis get weaker-than-average protection from COVID-19 vaccines, but stopping the drug for two weeks after a booster dose doubled patients' antibody response in a randomized trial. UK researchers studied 254 adults receiving methotrexate for their conditions who were about to get their third dose of a vaccine from Pfizer/BioNTech, Moderna , or AstraZeneca. Blood tests one and three months later showed antibody levels were more than twice as high among patients who paused methotrexate for two weeks as among patients who kept taking it.
(Bloomberg) -- The US Supreme Court turned away a challenge to New York’s Covid-19 vaccine requirement for health-care workers, rejecting an appeal from 16 people who objected to the shot on religious grounds.Most Read from BloombergStock Doomsayers Vindicated in Historic First Half: Markets WrapUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysThe Wheels Have Come Off Electric VehiclesDemocrats Weigh Paring Biden Tax Hike to Win Over ManchinSupreme Court Crimps Biden’s Climate Agend